Literature DB >> 7600528

Effect of arecanut, a masticatory, on hepatic drug metabolizing enzymes -SH content and lipid peroxidation in lactating mothers and their suckling neonates.

A Singh1, A R Rao.   

Abstract

The modulation caused by arecanut, a major ingredient of the masticatory substance betel quid, on biotransformation system enzymes, acid soluble sulfhydryl (-SH) content and lipid peroxidation was assessed in lactating mice and their neonates. Following parturition, dams were fed a 1% arecanut diet and F1 mice were nursed by their own mothers during the lactation period of 21 days. Arecanut induced significant increases in the levels of cytochrome b5, cytochrome P-450, glutathione S-transferase and malondialdehyde (MDA) in dams and their pups. However, it decreased the -SH content in lactating mice and F1 progeny; whether the F1 mice were exposed to the translactational dose of arecanut for 21 days or to a similar translactational dose plus a dietary dose of arecanut for additional post weaning period of 21 days, the pattern of changes in the profile of biotransformation system enzymes was essentially similar. The changes elicited by arecanut intake in the levels/activities of enzymes of the biotransformation system, MDA level and -SH content may enhance the susceptibility of neonatal stages of mice to the action of chemical carcinogens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600528     DOI: 10.1016/0304-3835(95)03776-s

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

Review 1.  A review of the systemic adverse effects of areca nut or betel nut.

Authors:  Apurva Garg; Pankaj Chaturvedi; Prakash C Gupta
Journal:  Indian J Med Paediatr Oncol       Date:  2014-01

2.  Areca nut components affect COX-2, cyclin B1/cdc25C and keratin expression, PGE2 production in keratinocyte is related to reactive oxygen species, CYP1A1, Src, EGFR and Ras signaling.

Authors:  Mei-Chi Chang; Yi-Jane Chen; Hsiao-Hua Chang; Chiu-Po Chan; Chien-Yang Yeh; Yin-Lin Wang; Ru-Hsiu Cheng; Liang-Jiunn Hahn; Jiiang-Huei Jeng
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.